ZIVO (Zivo Bioscience) ROCE %: 0.00% (As of Sep. 2025)


ZIVO Zivo Bioscience Inc ZIVO
14 GF Score
Price $3.15
! 5 Warning Signs
View Full Analysis

What is Zivo Bioscience ROCE %?

Zivo Bioscience ZIVO -27.08% 14 ROCE % is 0.00% as of Sep. 2025. GuruFocus rates ZIVO with a GF Score™ of 14/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zivo Bioscience's annualized ROCE % for the quarter that ended in Sep. 2025 was 0.00%.

Zivo Bioscience  (OTCPK:ZIVO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zivo Bioscience ROCE % Related Terms

Zivo Bioscience ROCE % Historical Data

* Premium members only.

The historical data trend for Zivo Bioscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zivo Bioscience ROCE % Chart

Zivo Bioscience Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -284.57 0.00 0.00

Zivo Bioscience Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ZIVO
14GF Score
Zivo Bioscience Inc ZIVO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zivo Bioscience ROCE % Calculation

Zivo Bioscience's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-13.362/( ( (0.556 - 2.762) + (1.643 - 2.042) )/ 2 )
=-13.362/( (-2.206+-0.399)/ 2 )
=-13.362/-1.3025
=1,025.87 %

Zivo Bioscience's ROCE % of for the quarter that ended in Sep. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2025 )  (Q: Jun. 2025 )(Q: Sep. 2025 )
=-4.08/( ( (0.703 - 2.96) + (0.559 - 3.614) )/ 2 )
=-4.08/( ( -2.257 + -3.055 )/ 2 )
=-4.08/-2.656
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Zivo Bioscience (ZIVO) has a ROCE % of 0.00% as of Sep. 2025.
Is Zivo Bioscience's ROCE % too high?
Zivo Bioscience's current ROCE % is 0.00%. Overall, Zivo Bioscience has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's ROCE % compare to INAB and LPCN?
Zivo Bioscience's ROCE % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Zivo Bioscience's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Zivo Bioscience's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current ROCE % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zivo Bioscience Business Description

Address 2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
14GF Score

Get the complete analysis for ZIVO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.15
Price